Patents
Patents for C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)
10/2006
10/03/2006US7115754 Pyrrolidine derivatives as oxytocin antagonists
10/03/2006US7115752 Substituted cyclic compounds
10/03/2006US7115739 Triazole compounds useful as protein kinase inhibitors
10/03/2006US7115644 Antiinflammatory agents; osteoarthritic; antihistamines; multiple sclerosis; antiulcer agents; skin disorders; graft versus host disease; abtidiabetic agents; Alzheimer's disease; antidiabetic agents
10/03/2006US7115643 simplified manner using considerably less process steps and with considerably improved yield and diastereoselectivity
10/03/2006US7115640 modulating farnesoid X receptor (FXR), liver X receptors (LXR alpha and LXR beta ) and/or orphan nuclear receptors; treatment of lipid, cardiovascular and neurodegenerative disorders
09/2006
09/28/2006US20060217568 Process for the preparation of compounds containing perfluoroalkanesulfonic acid groups
09/28/2006US20060217418 Antagonists for melanin concentrating hormone-1 receptors; antidepressants, anxiolytic agents; incontinence, obesity
09/27/2006EP1705169A2 Triphenylalkene derivatives and their use as selective estrogen receptor modulators
09/27/2006CN1276914C Novel cyclohexyl sulphones
09/26/2006US7112683 Cyclic sulfone containing retroviral protease inhibitors
09/26/2006US7112681 bifonazole; reduction of 4-phenyl-benzophenone, then subsequent reaction of the biphenyl phenyl carbinol with imidazole in solid phase under microwave energy
09/26/2006US7112600 A therapeutic agent for treating hepatitis C, based on polymerase inhibitory activity
09/26/2006US7112595 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
09/26/2006CA2424965C Novel coupler for use in oxidative hair dyeing
09/21/2006US20060211717 Quinoline and quinazoline derivatives and drugs containing the same
09/21/2006US20060211577 Benzenesulphonamide derivatives as herbicides or desiccant/defoliant compounds
09/21/2006DE19681478B4 R-(-)-(E)-[4-(2,4-Dichlorphenyl)-1,3-dithiolan-2-yliden]-1-imidazolylacetonitril,Verfahren zu seiner Herstellung und seine Verwendung R - (-) - (E) - [4- (2,4-dichlorophenyl) -1,3-dithiolan-2-ylidene] -1-imidazolylacetonitril, process for its preparation and its use
09/20/2006EP1702920A1 Pyrazole compounds useful as protein kinase inhibitors
09/20/2006EP1701953A1 Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
09/20/2006EP1554253A4 Imidazolium cxcr3 inhibitors
09/20/2006EP1353916B1 Pyrazole compounds useful as protein kinase inhibitors
09/19/2006US7109228 Pyrazole derivatives
09/19/2006US7109202 Such as 3-(2-(6-methyl-pyridin-2-ylamino)-5-(1,2,4)triazol-1-yl-thiazol-4 -yl)benzonitrile for treatment of inflammatory or obstrucive airways diseases
09/19/2006US7109197 Plant safening agents; nematocides; fungicides; bactericides; viricides
09/19/2006CA2149459C Acylated aminoalkanimidazoles and -triazoles
09/14/2006US20060205722 Such as N-{1-[2-(1,3-dioxan-2-yl)ethyl]piperidin-4-yl}-N-(4-fluorobenzyl)-2-[4-(2-hydroxy-2-methylpropoxy)phenyl]acetamide; selective inverse agonists of 5-HT2A receptor with minimal monamine receptors subtype activity; antipsychotics with reduced side effects
09/14/2006US20060205676 I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs; antiinflammatory, antitumor and antiischemic effects; asthma; nuclear factor kappa B inhibitors; 7-(2-hydroxyphenyl)-5-(3-piperidinyl)-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one
09/13/2006EP1414813B1 1,2,4-trioxolane antimalarials
09/13/2006EP1412364B1 Platelet adp receptor inhibitors
09/13/2006EP1392684B1 Thiazole compounds useful as inhibitors of protein kinases
09/13/2006EP1087951B9 Carbon substituted aminothiazole inhibitors of cyclin dependent kinases
09/12/2006US7105553 Thiazolyl amide derivatives
09/12/2006US7105544 N-{3-[1-(3-{[BIS(4-FLUOROPHENYL)ACETYL]AMINO}PROPYL)-4-PIPERIDINYL]PHENYL}-2-METHYLPROPANAMIDE; antagonists for melanin concentrating hormone-1 (MCH1) receptors; treating depression, anxiety, obesity
09/12/2006US7105529 A novel compound for treating alopecia induced by cancer chemotherapy or radiotherapy
09/12/2006CA2235986C Inhibitors of protein isoprenyl transferases
09/07/2006US20060199818 Inhibiting the activity of a 5-hydroxytryptamine 2A by administering a N-heterocyclyl (preferably 1,3-dioxan-5-yl)-4-[(N-substituted)(hetero)arylamino]piperidine in which the N-substituant is arylalkanoyl, arylthioalkanoyl, arylalkylaminocarbonyl or arylalkylaminothiocarbonyl group
09/06/2006EP1698627A1 Pyrazole compounds useful as protein kinase inhibitors
09/06/2006CN1273128C Substituted N-[(aminoiminomethyl or aminomethyl) phenyl] propyl amides
09/05/2006US7101898 Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes
08/2006
08/31/2006US20060194795 Platelet ADP receptor inhibitors
08/31/2006DE102005009517A1 Catalytic production of optionally substituted (hetero)aromatic nitriles, useful in the synthesis of e.g. agro products, comprises reacting aryl halides in the presence of copper compounds and cyanide donor yellow prussiate of potash
08/30/2006EP1318811B1 Cyclopentyl modulators of chemokine receptor activity
08/30/2006EP1020439B1 Cetp activity inhibitors
08/30/2006CN1826326A Method for the production of purified 1,3-substituted imidazolium salts
08/30/2006CN1272316C Benzamides and related inhibitors of factor Xa
08/29/2006US7098343 Polycyclic compounds containing a central trivalent atom to which is attached either direct or indirectly via a linker a two or three ring system and a ring system contining sulphamate group as substituent; steroid sulfatase inhibitor
08/29/2006US7098330 Pyrazolylamine substituted quinazoline compounds useful as protein kinase inhibitors
08/29/2006US7098239 Dipeptidyl peptidase inhibitors for the treatment of diabetes
08/29/2006CA2112779C Arylsulfonamido-substituted hydroxamic acids
08/23/2006EP1692144A2 Organometallic transition metal compound, biscyclopentadienyl ligand system, catalyst system and preparation of polyolefins
08/23/2006EP0837052B1 Bicyclic amino derivatives and pgd 2 antagonist containing the same
08/22/2006US7094792 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
08/22/2006CA2242102C Quinazoline derivatives as antitumor agents
08/22/2006CA2222788C Novel vinyl sulfide compounds and a process for their preparation
08/16/2006CN1269824C Production of ionic liquids
08/16/2006CN1269800C Benzoylcyclohexandiones, method for the production and use thereof as herbicides and plant growth regulators
08/15/2006US7091247 urotensin antagonists; vasoactive agents
08/15/2006US7091227 Serine/threonine and tyrosine kinases inhibitors
08/15/2006US7091217 Chemokine receptor binding heterocyclic compounds
08/15/2006US7091158 Substituted thienyl(amino)sulphonylureas
08/15/2006CA2215476C Arginine analogues having nitric oxide synthase inhibitor activity
08/10/2006US20060178415 Azole derivatives as antifungal agents
08/09/2006EP1688412A2 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands
08/09/2006EP1688041A1 An agricultural and horticultural disease controller and a method for controlling the diseases
08/09/2006EP1401806B1 Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents
08/09/2006EP1317451B1 Chemokine receptor binding heterocyclic compounds
08/09/2006EP1276743B1 Ion liquids derived from lewis acid based on titanium, niobium, tantalum or antimony, and uses thereof
08/09/2006EP0988301B1 Imidazolyl-cyclic acetals
08/08/2006US7087635 3-substituted oxindole β3 agonists
08/08/2006US7087624 Substituted pyrazole compounds
08/08/2006US7087603 Pyrazole compounds useful as protein kinase inhibitors
08/08/2006US7087601 Psychological disorders; anxiolytic agents; antidepressants; analgesics ; schizophrenia
08/08/2006US7087600 Anticancer agents; side effect reduction
08/03/2006WO2003072033A3 Common ligand mimics: thiazolidinediones and rhodanines
08/03/2006US20060173075 P-(sulfonyl) aryl and heteroarylamines-as anti-inflammatory agents
08/03/2006US20060173057 Methods of treating factor VIIa-associated conditions with compounds having an amine nucleus
08/03/2006US20060173034 Novel 4-anilinoquinoline-3-carboxamides
08/02/2006EP0986551B1 Sulfonamide derivatives, their production and use
08/01/2006US7084290 Compounds used in batteries, capacitors and galvanic cells
08/01/2006US7084162 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
08/01/2006CA2338214C Heterocyclic compounds as inhibitors of rotamase enzymes
07/2006
07/27/2006DE102005003634A1 Triarylamin-Derivate II mit raumfüllenden Seitengruppen und Verwendung in elektrolumineszenten und elektrofotografischen Vorrichtung Triarylamine derivatives II with room-filling side groups and use in electroluminescent and electrophotographic apparatus
07/26/2006EP1683789A1 Substituted arylsulfonyl(thio)ureas as herbicides
07/26/2006EP1682140A2 Methods of use of thrombin receptor antagonists
07/26/2006CN1266138C Gyrase imhibitors and uses thereof
07/26/2006CN1266118C Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
07/26/2006CN1266112C Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
07/25/2006US7081466 anticarcinogenic agents with improved efficacy against multidrug resistant tumors; improved oral bioavailability and side effect reduction
07/25/2006US7081454 Anticancer agents
07/25/2006US7081140 Developer components and their use for dyeing keratinic fibers
07/25/2006CA2159603C Quinolines as type iv phosphodiesterase inhibitors
07/20/2006US20060160797 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
07/20/2006DE102005001053A1 Quadratsäurederivate Squaric acid derivatives
07/19/2006EP1680479A1 New organic compound and organic light emitting device using the same
07/19/2006CN1264823C Process for preparing retroviral protease inhibitors and its intermediates
07/19/2006CN1264498C Primary intermediates for oxidative coloration of hair
07/18/2006US7078426 Central nervous system disorders
07/18/2006US7078369 Pyridine, pyrimidine or triazine derivatives; selectivity; safe for agricultural plants including transgenics; synthesis
07/13/2006WO2006073967A1 Piperidine derivatives as prodrugs of potassium channel inhibitors
1 ... 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 ... 163